Matinas BioPharma Holdings (MTNB) Notes Payables (2015 - 2019)
Matinas BioPharma Holdings (MTNB) posted quarterly Notes Payables of $79937.0 for Q1 2019, up 87.83% year-over-year from $42559.0 in Q1 2018, and down 60.0% quarter-over-quarter from $199842.0 in Q4 2018.
Matinas BioPharma Holdings (MTNB) Notes Payables (2015 - 2019) Analysis & Trends
Matinas BioPharma Holdings (MTNB) has reported Notes Payables for 5 consecutive years, with $79937.0 the latest figure, recorded in Q1 2019.
- In Q1 2019, Notes Payables rose 87.83% year-over-year to $79937.0; the TTM figure through Mar 2019 stood at $79937.0 (up 87.83% YoY), while the FY2018 annual figure was $199842.0, up 17.39% from the prior year.
- Notes Payables eased to $79937.0 in Q1 2019 per MTNB's latest filing, from $199842.0 in the prior quarter.
- Across five years, Notes Payables topped out at $319746.0 in Q3 2018 and bottomed at $10000.0 in Q1 2015.
- Historically, Notes Payables has averaged $124530.8 across 5 years, with a median of $98991.5 in 2016.
- Annual changes were most pronounced in 2016 — Notes Payables soared 1788.73% — and 2018, when it dropped 9.87%.
- Matinas BioPharma Holdings' Notes Payables stood at $10000.0 in 2015, then soared by 1080.46% to $118046.0 in 2016, then jumped by 44.21% to $170236.0 in 2017, then gained by 17.39% to $199842.0 in 2018, then slumped by 60.0% to $79937.0 in 2019.
- Business Quant data shows MTNB's Notes Payables at $79937.0 in Q1 2019, $199842.0 in Q4 2018, and $319746.0 in Q3 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Matinas BioPharma Holdings | 1.19 Mn | 375,426.61 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2019 | 79,937.00 |
| Dec 31, 2018 | 199,842.00 |
| Sep 30, 2018 | 319,746.00 |
| Mar 31, 2018 | 42,559.00 |
| Dec 31, 2017 | 170,236.00 |
| Sep 30, 2017 | 297,912.00 |
| Mar 31, 2017 | 47,218.00 |
| Dec 31, 2016 | 118,046.00 |
| Sep 30, 2016 | 188,873.00 |
| Sep 30, 2015 | 10,000.00 |
| Jun 30, 2015 | 10,000.00 |
| Mar 31, 2015 | 10,000.00 |